Side Effects Xarelto – A History Told Through FDA Warnings
- Last Updated: August 4th, 2023
Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
Fact-Checked
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Side Effects Xarelto – A History Told Through FDA Warnings
Table of Contents
Side Effects Xarelto
The side effects Xarelto story starts with initial approval in 2011, and the blood thinner has had an eventful journey, receiving several warnings from the U.S. Food and Drug Administration (FDA), as well as required labeling and advertising changes.
July 2011 – June 28, 2013
Xarelto is approved by the FDA for the treatment of deep vein thrombosis in patients undergoing knee replacement and hip replacement surgery, to reduce the risk of stroke in people with abnormal heart rhythm, and to treat and reduce the risk of deep vein thrombosis or pulmonary embolism.
August 2013
Xarelto makers Janssen Pharmaceuticals (Johnson & Johnson subsidiary) and Bayer AG were required to make changes to their advertisements after the FDA claimed that the companies downplayed the possible side effects associated with the drug.
Xarelto was also required by the FDA to carry a boxed warning advising consumers and the medical community that premature discontinuation of the drug would increase the risk of thrombotic events and spinal/epidural hematoma.
January 2014
The FDA issued five warnings and precautions regarding side effects Xarelto:
- Physicians were advised to promptly evaluate any signs or symptoms of blood loss and consider the need for blood replacement in Xarelto patients.
- A warning was issued advising that no specific antidote is currently available to counteract the anticoagulant effects of Xarelto.
- Practitioners were warned to avoid combining Xarelto with P-gp and strong CYP3A4 inhibitors and inducers.
- Because the safety and efficacy of Xarelto had not been studied in people with prosthetic heart valves, the medication was not recommended for those patients.
- Xarelto was not recommended as an alternative to heparin in patients with pulmonary embolism.
February – March 2014
A side effects Xarelto boxed warning was issued by the FDA advising users of the dangerous side effects of Xarelto, including the lack of an antidote, and the risks associated with using the medication with epidural anesthesia and spinal puncture.
December 2014
More label changes: the adverse reaction thrombocytopenia was added to the Xarelto label, and the adverse reaction term “cytolytic hepatitis” was replaced with “hepatitis.”
Side effects Xarelto moves from regulatory actions to lawsuits.
Since Xarelto’s approval five years ago, Xarelto Lawsuits have been filed against Johnson & Johnson and Bayer AG alleging Xarelto side effects including gastrointestinal bleeding, rectal bleeding, internal bleeding, stroke, heart attack, pulmonary embolism, epidural hematoma, and brain hemorrhages.
Some 2,800 cases have been consolidated into multidistrict litigation (MDL) in Eastern Louisiana and nearly 700 have been combined into a mass tort program in the state of Pennsylvania.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
